Skip to main content
Top
Published in: Journal of Infection and Chemotherapy 3/2008

01-06-2008 | Note

Molecular characteristics of serotype 3 Streptococcus pneumoniae isolates among community-acquired pneumonia patients in Japan

Authors: Rie Isozumi, Yutaka Ito, Tadashi Ishida, Toyohiro Hirai, Isao Ito, Ko Maniwa, Michio Hayashi, Hitoshi Kagioka, Masataka Hirabayashi, Koichi Onaru, Hiromi Tomioka, Keisuke Tomii, Iwao Gohma, Makoto Osawa, Seiichiro Imai, Shunji Takakura, Yoshitsugu Iinuma, Kazuo Chin, Satoshi Ichiyama, Michiaki Mishima, the Kansai Community Acquired Pneumococcal Pneumonia Study Group

Published in: Journal of Infection and Chemotherapy | Issue 3/2008

Login to get access
Metadata
Title
Molecular characteristics of serotype 3 Streptococcus pneumoniae isolates among community-acquired pneumonia patients in Japan
Authors
Rie Isozumi
Yutaka Ito
Tadashi Ishida
Toyohiro Hirai
Isao Ito
Ko Maniwa
Michio Hayashi
Hitoshi Kagioka
Masataka Hirabayashi
Koichi Onaru
Hiromi Tomioka
Keisuke Tomii
Iwao Gohma
Makoto Osawa
Seiichiro Imai
Shunji Takakura
Yoshitsugu Iinuma
Kazuo Chin
Satoshi Ichiyama
Michiaki Mishima
the Kansai Community Acquired Pneumococcal Pneumonia Study Group
Publication date
01-06-2008
Publisher
Springer Japan
Published in
Journal of Infection and Chemotherapy / Issue 3/2008
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-008-0600-9

Other articles of this Issue 3/2008

Journal of Infection and Chemotherapy 3/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.